These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1087180

  • 1. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
    Pinedo HM, Zaharko DS, Bull JM, Chabner BA.
    Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
    [Abstract] [Full Text] [Related]

  • 2. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H, Uitendaal MP, van der Grint L, Leyva A, Pinedo HM.
    Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
    [Abstract] [Full Text] [Related]

  • 3. Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action.
    Strømhaug A, Warren DJ, Slørdal L.
    Exp Hematol; 1995 May; 23(5):439-43. PubMed ID: 7720815
    [Abstract] [Full Text] [Related]

  • 4. Formation of methotrexate polyglutamates in purified myeloid precursor cells from normal human bone marrow.
    Koizumi S, Curt GA, Fine RL, Griffin JD, Chabner BA.
    J Clin Invest; 1985 Mar; 75(3):1008-14. PubMed ID: 2579975
    [Abstract] [Full Text] [Related]

  • 5. Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum.
    Sobrero AF, Bertino JR.
    Int J Cell Cloning; 1986 Jan; 4(1):51-62. PubMed ID: 2936838
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
    Rosenblatt DS, Whitehead VM, Matiaszuk NV, Pottier A, Vuchich MJ, Beaulieu D.
    Mol Pharmacol; 1982 May; 21(3):718-22. PubMed ID: 6180291
    [Abstract] [Full Text] [Related]

  • 7. The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion.
    Pinedo HM, Zaharko DS, Bull J, Chabner BA.
    Cancer Res; 1977 Feb; 37(2):445-50. PubMed ID: 832268
    [Abstract] [Full Text] [Related]

  • 8. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
    Eleff M, Franks PE, Wampler GL, Collins JM, Goldman ID.
    Cancer Treat Rep; 1985 Feb; 69(7-8):867-74. PubMed ID: 2410122
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate cytotoxicity: studies on its reversal by folates and nucleosides.
    Leyva A, Nederbragt H, Lankelma J, Pinedo HM.
    Cancer Treat Rep; 1981 Feb; 65 Suppl 1():45-50. PubMed ID: 6173122
    [Abstract] [Full Text] [Related]

  • 10. Resistance of human bone marrow CFUC to high-dose methotrexate cytotoxicity.
    Koizumi S, Yamagami M, Ueno Y, Miura M, Taniguchi N.
    Exp Hematol; 1980 May; 8(5):635-40. PubMed ID: 7461061
    [Abstract] [Full Text] [Related]

  • 11. Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
    Cole PD, Smith AK, Kamen BA.
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):111-6. PubMed ID: 12172974
    [Abstract] [Full Text] [Related]

  • 12. Reversal of methotrexate cytotoxicity to human bone marrow cells and leukemic K562 cells by leucovorin: methotrexate polyglutamates formation as a possible important factor.
    Koizumi S, Ueno Y, Ohno I, Ichihara T, Tamaru Y, Matsukawa H.
    Jpn J Cancer Res; 1990 Nov; 81(11):1162-7. PubMed ID: 1702414
    [Abstract] [Full Text] [Related]

  • 13. 7-Hydroxymethotrexate cytotoxicity and selectivity in a human Burkitt's lymphoma cell line versus human granulocytic progenitor cells: rescue by folinic acid and nucleosides.
    Fabre I, Fabre G, Cano JP.
    Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1247-54. PubMed ID: 3493143
    [Abstract] [Full Text] [Related]

  • 14. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T, Ohnuma T, Takahashi I, Scanlon K, Kamen BA, Holland JF.
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [Abstract] [Full Text] [Related]

  • 15. [Effect of rescue treatment with high doses of methotrexate (MTX) followed by leucovorin (LV) on neoplastic cells (HeLa line) and normal sensitized peripheral lymphocytes].
    Ruano A, Alvarez-Rodríguez Y, Valladares Y.
    Rev Esp Oncol; 1982 May; 29(4):665-73. PubMed ID: 6985426
    [Abstract] [Full Text] [Related]

  • 16. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
    Samuels LL, Straw JA.
    Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry.
    Taylor IW, Tattersall MH.
    Cancer Res; 1981 Apr; 41(4):1549-58. PubMed ID: 6163527
    [Abstract] [Full Text] [Related]

  • 18. Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexate.
    Howell SB, Krishan A, Frei E.
    Cancer Res; 1979 Apr; 39(4):1315-20. PubMed ID: 311245
    [Abstract] [Full Text] [Related]

  • 19. Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro.
    Fabre I, Fabre G, Goldman ID.
    Cancer Res; 1984 Aug; 44(8):3190-5. PubMed ID: 6204743
    [Abstract] [Full Text] [Related]

  • 20. Long-term bone marrow culture as a model for host toxicity: the effect of methotrexate on hematopoiesis and adherent layer function.
    Williams LH, Udupa KB, Lipschitz DA.
    Exp Hematol; 1988 Jan; 16(1):80-7. PubMed ID: 3257191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.